📰 Inst Inc News
Inst Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Inst Inc. Real-time updates on events, politics, business and more.
May 3, 2024
In inter partes review proceedings, the Patent Trial and Appeal Board has historically been reticent to consider arguments raised for the first time in a petitioner's reply.
August 8, 2023
The Federal Circuit held in a precedential decision today that an inter partes review petitioner must be given the opportunity to present evidence of anticipation or obviousness under a new claim construction when that construction is first proposed by a patent owner in its response following the institution decision.
August 3, 2023
In 2019, the Patent Trial and Appeal Board initiated a pilot program allowing patent owners to request preliminary guidance on a motion to amend.
July 17, 2023
One of the wonderful (as in, it makes one wonder) and frustrating (which needs no explanation) aspects of patent law is that just when you think a question is settled it either isn't or...
July 15, 2023
More than a decade ago Congress considered, and rejected, any standing requirements for post-grant proceedings. Congress could hardly have been more explicit. The provisions were...
May 22, 2023
The scope and applicability of inter partes review ("IPR") estoppel continues to develop and reshape patent litigation across the country.
May 15, 2023
In a late-March 2023 decision out of the U.S. District Court for the Southern District of California, a court denied a plaintiff's request for attorneys' fees against a defendant who filed "objectively specious" counterclaims ...
May 11, 2023
In a late-March 2023 decision out of the U.S. District Court for the Southern District of California, a court denied a plaintiff's request for attorneys' fees against a defendant who...
July 28, 2022
In California Institute of Technology v. Broadcom Limited,1 the Federal Circuit overruled prior precedent and clarified that inter partes review (IPR) estoppel applies not just to...
March 24, 2022
In June 2021, the US Patent and Trademark Office (USPTO) published an update to its study of America Invents Act (AIA) trials involving challenges to Orange Book-listed and biologic...